quinacrine has been researched along with Chlamydia Infections in 1 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Chlamydia Infections: Infections with bacteria of the genus CHLAMYDIA.
Excerpt | Relevance | Reference |
---|---|---|
"Quinacrine has been widely used in treatment of parasitic diseases such as malaria and giardiasis, and in the treatment of autoimmune diseases." | 6.49 | Quinacrine-induced occlusive fibrosis in the human fallopian tube is due to a unique inflammatory response and modification of repair mechanisms. ( Fail, PA; Growe, RG; Lippes, J; Luster, MI, 2013) |
"Quinacrine has been widely used in treatment of parasitic diseases such as malaria and giardiasis, and in the treatment of autoimmune diseases." | 2.49 | Quinacrine-induced occlusive fibrosis in the human fallopian tube is due to a unique inflammatory response and modification of repair mechanisms. ( Fail, PA; Growe, RG; Lippes, J; Luster, MI, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Growe, RG | 1 |
Luster, MI | 1 |
Fail, PA | 1 |
Lippes, J | 1 |
1 review available for quinacrine and Chlamydia Infections
Article | Year |
---|---|
Quinacrine-induced occlusive fibrosis in the human fallopian tube is due to a unique inflammatory response and modification of repair mechanisms.
Topics: Animals; Cell Adhesion; Chlamydia Infections; Chlamydia trachomatis; Contraception; Drug Implants; E | 2013 |